130 related articles for article (PubMed ID: 18617914)
1. Conditioned medium from Ad-IFN-alpha-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect.
Zhang X; Dong L; Chapman E; Benedict WF
Cancer Gene Ther; 2008 Dec; 15(12):817-22. PubMed ID: 18617914
[TBL] [Abstract][Full Text] [Related]
2. Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced.
Zhang XQ; Dunner K; Benedict WF
Cancer Gene Ther; 2010 Aug; 17(8):579-84. PubMed ID: 20489789
[TBL] [Abstract][Full Text] [Related]
3. Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker.
Fisher MB; Zhang XQ; McConkey DJ; Benedict WF
Cancer Gene Ther; 2009 Jul; 16(7):567-72. PubMed ID: 19197325
[TBL] [Abstract][Full Text] [Related]
4. Direct gene transfer of adenoviral-mediated interferon α into human bladder cancer cells but not the bystander factors produced induces endoplasmic reticulum stress-related cytotoxicity.
Zhang XQ; Yang Z; Benedict WF
Cancer Gene Ther; 2011 Apr; 18(4):260-4. PubMed ID: 21183949
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral-mediated interferon alpha overcomes resistance to the interferon protein in various cancer types and has marked bystander effects.
Zhang X; Yang Z; Dong L; Papageorgiou A; McConkey DJ; Benedict WF
Cancer Gene Ther; 2007 Mar; 14(3):241-50. PubMed ID: 17096027
[TBL] [Abstract][Full Text] [Related]
6. Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein.
Benedict WF; Tao Z; Kim CS; Zhang X; Zhou JH; Adam L; McConkey DJ; Papageorgiou A; Munsell M; Philopena J; Engler H; Demers W; Maneval DC; Dinney CP; Connor RJ
Mol Ther; 2004 Sep; 10(3):525-32. PubMed ID: 15336652
[TBL] [Abstract][Full Text] [Related]
7. Direct cytotoxicity produced by adenoviral-mediated interferon α gene transfer in interferon-resistant cancer cells involves ER stress and caspase 4 activation.
Yang Z; Zhang XQ; Dinney CN; Benedict WF
Cancer Gene Ther; 2011 Sep; 18(9):609-16. PubMed ID: 21681220
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer.
Nagabhushan TL; Maneval DC; Benedict WF; Wen SF; Ihnat PM; Engler H; Connor RJ
Cytokine Growth Factor Rev; 2007; 18(5-6):389-94. PubMed ID: 17692556
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells.
Zhang X; Multani AS; Zhou JH; Shay JW; McConkey D; Dong L; Kim CS; Rosser CJ; Pathak S; Benedict WF
Cancer Res; 2003 Feb; 63(4):760-5. PubMed ID: 12591722
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.
Adam L; Black PC; Kassouf W; Eve B; McConkey D; Munsell MF; Benedict WF; Dinney CP
J Urol; 2007 May; 177(5):1900-6. PubMed ID: 17437845
[TBL] [Abstract][Full Text] [Related]
11. Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell.
He XD; Wang ZP; Wei HY; Zhou Q; Wang DG; Tian JQ; Fu SJ; Rodriguez R
Urol Int; 2009; 82(2):209-13. PubMed ID: 19322012
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species and nitric oxide signaling in bystander cells.
Jella KK; Moriarty R; McClean B; Byrne HJ; Lyng FM
PLoS One; 2018; 13(4):e0195371. PubMed ID: 29621312
[TBL] [Abstract][Full Text] [Related]
13. Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro.
Liu W; O'Donnell MA; Chen X; Han R; Luo Y
Cancer Immunol Immunother; 2009 Oct; 58(10):1647-55. PubMed ID: 19214503
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation.
Tao Z; Connor RJ; Ashoori F; Dinney CP; Munsell M; Philopena JA; Benedict WF
Cancer Gene Ther; 2006 Feb; 13(2):125-30. PubMed ID: 16082384
[TBL] [Abstract][Full Text] [Related]
16. Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer.
Navai N; Benedict WF; Zhang G; Abraham A; Ainslie N; Shah JB; Grossman HB; Kamat AM; Dinney CP
Ann Surg Oncol; 2016 Nov; 23(12):4110-4114. PubMed ID: 27387678
[TBL] [Abstract][Full Text] [Related]
17. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
[TBL] [Abstract][Full Text] [Related]
18. Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.
Wang L; Zhang Y; Zhao J; Xiao E; Lu J; Fu S; Wang Z
Tumour Biol; 2014 Nov; 35(11):10879-90. PubMed ID: 25085582
[TBL] [Abstract][Full Text] [Related]
19. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
20. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
Teng J; Wang ZY; Jarrard DF; Bjorling DE
Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
